APTOFAptose Biosciences Inc.同业对比
Aptose Biosciences Inc. 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APTOF本股 | — | — | — | — | — | -0.1%#10 | — | — | — | — | — | — |
| ABPO | — | — | — | — | 50.0%#5 | 60.0%#4 | -4618.6%#7 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#3 | 37.8%#6 | -38.6%#5 | — | — | — | — | — |
| AGMB | $483M#5 | — | — | — | — | — | — | — | — | — | — | — |
| AGTX | — | — | — | — | -100.0%#9 | 14.4%#8 | — | — | — | — | — | — |
| ALVO | $1.2B#3 | — | — | 2.0x#2 | 19.7%#6 | 112.0%#2 | 13.3%#3 | — | — | — | -55.1%#5 | — |
| ALVOW | $100M#7 | — | — | 0.2x#1 | 19.7%#6 | 112.0%#2 | 13.3%#3 | — | — | — | -74.6%#6 | — |
| APTN | — | — | — | — | — | -65.5%#12 | — | — | — | — | — | — |
| ARGX | $53.5B#1 | — | — | 1506.5x#5 | 254.4%#2 | 55.1%#5 | 2965.7%#1 | — | — | — | 29.2%#2 | — |
| AUTL | $562M#4 | — | 5.2x#2 | 7.4x#4 | 644.9%#1 | -30.3%#11 | -358.9%#6 | -264.2%#2 | — | — | -10.2%#3 | — |
| BNTX | $23.5B#2 | — | — | — | — | — | — | — | — | — | -15.9%#4 | — |
| CGEN | $228M#6 | 6.3x#1 | 2.2x#1 | 3.1x#3 | 161.1%#4 | 348.4%#1 | 43.1%#2 | 34.4%#1 | — | — | 65.1%#1 | — |
| CKDXF | — | — | — | — | -80.0%#8 | 26.1%#7 | -623048.0%#9 | — | — | — | — | — |
| CLDWW | — | — | — | — | — | 10.1%#9 | -44977.8%#8 | -403.4%#3 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-08-09。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议